A5056552067- Cardiovascular Health and Risk Factors
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
- Cardiac Health and Mental Health
- Health disparities and outcomes
- Lipoproteins and Cardiovascular Health
- Patient Satisfaction in Healthcare
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- Healthcare Systems and Public Health
- Primary Care and Health Outcomes
- Cardiovascular Disease and Adiposity
- COVID-19 Clinical Research Studies
- Diversity and Career in Medicine
- Medication Adherence and Compliance
- Pharmaceutical industry and healthcare
- Economic and Financial Impacts of Cancer
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Long-Term Effects of COVID-19
- Emergency and Acute Care Studies
- Physical Activity and Health
- Cancer, Lipids, and Metabolism
- COVID-19 and healthcare impacts
Florida Atlantic University
2022-2024
West Virginia University
2024
Sanford USD Medical Center
2024
Sanford Medical Center
2024
Bethesda Hospital East
2023
Baptist Health South Florida
2016-2022
Baptist Hospital of Miami
2016-2021
Duke Medical Center
2018
Yale New Haven Hospital
2016-2017
Yale University
2016-2017
Statins remain a mainstay in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD).To detail trends use total out-of-pocket (OOP) expenditures associated with statins representative US adult population from 2002 to 2013.This retrospective longitudinal cohort study was conducted January December 2013. Demographic, medical condition, prescribed medicine information adults 40 years older between 2013 were obtained Medical Expenditure Panel Survey database.Estimated...
Background Atherosclerotic cardiovascular disease ( ASCVD ) accounts for approximately one third of deaths in women. Although there is an established relationship between positive patient experiences, health-related quality life, and improved health outcomes, little known about gender differences patient-reported outcomes among patients. We therefore compared patient-centered individuals with . Methods Results Data from the 2006 to 2015 Medical Expenditure Panel Survey, a nationally...
Consumer-reported patient-provider communication (PPC) assessed by Consumer Assessment of Health Plans Survey in ambulatory settings is incorporated as a complementary value metric for patient-centered care chronic conditions pay-for-performance programs. In this study, we examine the relationship PPC with select indicators nationally representative US adult population established atherosclerotic cardiovascular disease.The study consisted sample 6810 individuals (aged ≥18 years),...
Physical activity (PA) has an established favorable impact on cardiovascular disease (CVD) outcomes and quality of life. In this study, we aimed to estimate the economic effect moderate-vigorous PA medical expenditures utilization from a nationally representative cohort with without CVD.The 2012 Medical Expenditure Panel Survey data were analyzed. Our study population was limited noninstitutionalized US adults ≥18 years age. Variables interest included CVD (coronary artery disease, stroke,...
The American Heart Association's 2020 Strategic Goals emphasize the value of optimizing risk factor status to reduce burden morbidity and mortality. In this study, we aimed quantify overall marginal impact favorable cardiovascular (CRF) profile on healthcare expenditure resource utilization in United States among those with without disease (CVD).The study population was derived from 2012 Medical Expenditure Panel Survey (MEPS). Direct indirect costs were calculated for all-cause utilization....
Background Evidence supporting nonstatin lipid‐lowering therapy in atherosclerotic cardiovascular disease risk reduction is variable. We aim to examine utilization and expenditures the United States between 2002 2013. Methods Results used Medical Expenditure Panel Survey database estimate national trends use cost (total out‐of‐pocket, adjusted 2013 US dollars using a gross domestic product deflator) among adults 40 years or older. Nonstatin users increased from 3 million (2.5%) 2002‐2003...
There is increasing evidence of the role psychosocial factors play as determinants cardiovascular health (CVH). We examined association between self-rated (SRH) and ideal CVH among employees a large healthcare organization.Data were collected in 2014 from Baptist Health South Florida during an annual voluntary risk assessment wellness fair. SRH was measured using self-administered questionnaire where responses ranged poor, fair, good, very good to excellent. A score (the proxy for CVH) that...
Atherosclerotic cardiovascular disease (ASCVD) causes most deaths in the United States and accounts for highest healthcare spending. The association between modifiable risk factors (MRFs) of ASCVD pharmaceutical expenditures are largely unknown.We examined MRFs among adults with using 2012 2013 Medical Expenditure Panel Survey. A 2-part model was used while accounting survey's complex design to obtain nationally representative results. All costs were adjusted US dollars gross domestic...
Background Atherosclerotic cardiovascular disease ( ASCVD ) and cancer are among the leading causes of economic burden, morbidity, mortality in United States. We aimed to quantify overall impact modifiable risk factor CRF profile on healthcare expenditures those with without and/or cancer. Methods Results The 2012–2013 Medical Expenditure Panel Survey, a nationally representative adult sample (≥40 years), was utilized for study. Variables included , (hypertension, diabetes mellitus,...
Abstract Aims The Cardiac Lipid Panel (CLP) is a newly discovered panel of metabolite‐based biomarkers that has shown to improve the diagnostic value N terminal pro B type natriuretic peptide (NT‐proBNP). However, little known about its usefulness in predicting outcomes. In this study, we developed risk score for 4‐year cardiovascular death elderly chronic heart failure (CHF) patients using CLP. Methods and results From Insufficiency Bisoprolol Study Elderly trial, included 280 with CHF aged...
Abstract The cardiac lipid panel (CLP) is a novel of metabolomic biomarkers that has previously shown to improve the diagnostic and prognostic value for CHF patients. Several scores have been developed cardiovascular disease risk, but their use limited specific populations precision still inadequate. We compared risk score using CLP plus NT-proBNP four commonly used scores: Seattle Heart Failure Model (SHFM), Framingham (FRS), Barcelona bio-HF (BCN Bio-HF) Meta-Analysis Global Group in...
Postpartum hypertension can significantly increase maternal morbidity and mortality, hence it requires prompt interdisciplinary evaluation interventions. We present a case of gravid patient with significant comorbidities who required multiple treatments care from several specialists following complicated vaginal delivery. The outcome this depended on focused differential diagnosis consultation the teams involved. This report illustrates importance effective communication an approach in...
Diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD) both increase the risk for a major adverse cardiac event, are therefore considered priority conditions clinically. Although guidelines encourage clinicians to treat them similarly, many researchers do not consider DM an ASCVD risk-equivalent. However, from healthcare system standpoint it is more important determine whether economic burden equivalent ASCVD. Using data Household Component of 2010-2013 Medical Expenditure...